The DOI matches its Crossref record.
A new statistical procedure for testing equivalence in two-group comparative bioavailability trials
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Comparisons between expert and non-expert listeners, participants with and without known hearing issues and testing modalities were undertaken using the two one sided tests (TOST) of Hauck and Anderson (1984) and Lakens (2017).”
From A time-scale modification dataset with subjective quality labels (2020) · cites this paper as Hauck and Anderson (1984)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 13
- S. Anderson and W. W. Hauck. A new procedure for testing equivalence in comparative bioavailability and other clinical trials.Comm. Stat. A12:2663–2692 (1983). · DOI
- C. W. Dunnett and M. Gent. Significance testing to establish equivalence between treatments, with special reference to data in the form of 2×2 tables.Biometrics 33: 593–602 (1977). · DOI
- T. B. L. Kirkwood. Bioequivalence testing—a need to rethink.Biometrics 37: 589–591 (1981). · DOI
- D. Mandallaz and J. Mau. Comparison of different methods for decision-making in bioequivalence assessment.Biometrics 37: 213–222 (1981). · DOI
- C. M. Metzler. Bioavailability—a problem in equivalence.Biometrics 30: 309–317 (1974). · DOI
- C. M. Metzler and D. C. Huang. Statistical methods for bioavailability and bioequivalence.Clin. Res. Pract. Drug Res. Affairs 1: 109–132 (1983). · DOI
- M. R. Selwyn, A. P. Dempster, and N. R. Hall. A Bayesian approach to bioequivalence for the 2×2 changeover design.Biometrics 37: 11–21 (1981). · DOI
- W. J. Westlake. Use of confidence intervals in analysis of comparative bioavailability trials.J. Pharm. Sci 61: 1340–1341 (1972). · DOI
- W. J. Westlake. The design and analysis of comparative blood-level trials. In J. Swarbrick (ed),Current Concepts in the Pharmaceutical Sciences, Dosage Form Design and Bioavailability, Lea & Febiger, Philadelphia, 1973, pp. 149–179.
- W. J. Westlake. Symmetric confidence intervals for bioequivalence trials.Biometrics 32: 741–744 (1976). · DOI
- W. J. Westlake. Design and statistical evaluation of bioequivalence studies in man. In J. Blanchard, R. W. Sawchuk, and B. B. Brodie (ed),Principles and Perspectives in Drug Bioavailability, Karger, Basel, 1979, pp. 192–210.
- W. J. Westlake. Response to bioequivalence testing—a need to rethink.Biometrics 37: 591–593 (1981).
- D. Clayton and A. Leslie. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.J. Int. Med. Res. 9: 470–477 (1981). · DOI
Cited by
Schuirmann, D. J. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01068419 · Cited by 2,696
Lakens, D. (2017) · Social Psychological and Personality Science · doi:10.1177/1948550617697177 · Cited by 2,161
“Equivalence testing originates from the field of pharmacokinetics (Hauck & Anderson, 1984), where researchers sometimes want to show that a new cheaper drug works just as well as an existing drug (for an overview, see Senn, 2007, Chapters 15 and 22).”
Validity of Consumer-Based Physical Activity Monitors
LEE, J.-M., KIM, Y., & WELK, G. J. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000287 · Cited by 401
T‐MoCA: A valid phone screen for cognitive impairment in diverse community samples
Katz, M. J., Wang, C., Nester, C. O., Derby, C. A., Zimmerman, M. E., Lipton, R. B., Sliwinski, M. J., & Rabin, L. A. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12144 · Cited by 214
Meyners, M. (2012) · Food Quality and Preference · doi:10.1016/j.foodqual.2012.05.003 · Cited by 130
Metadata
- Authors
- Hauck, W. W., & Anderson, S.
- Venue
- Journal of Pharmacokinetics and Biopharmaceutics
- Published
- 1984-02
- Volume
- 12
- Issue
- 1
- Pages
- 83-91
- ISSN
- 0090-466X
- Cited by
- 168
- References
- 0
- Language
- en
- Update notices
- correction (1984-12-01)
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A new statistical procedure for testing equivalence in two-group comparative bioavailability trials. https://app.cochat.ai/papers/10.1007/bf01063612
- The paper
- Hauck, W. W., & Anderson, S. (1984). A new statistical procedure for testing equivalence in two-group comparative bioavailability trials. Journal of Pharmacokinetics and Biopharmaceutics. https://doi.org/10.1007/bf01063612
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
